NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 261 filers reported holding NATERA INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,351,424 | +1724.8% | 143,535 | +1906.6% | 0.02% | +1500.0% |
| Q2 2023 | $348,065 | -74.1% | 7,153 | -76.6% | 0.00% | -85.7% |
| Q3 2022 | $1,342,000 | -80.0% | 30,632 | -81.4% | 0.01% | -75.9% |
| Q1 2022 | $6,705,000 | +83.8% | 164,830 | +412.9% | 0.03% | +107.1% |
| Q2 2021 | $3,648,000 | -1.3% | 32,134 | -11.7% | 0.01% | -36.4% |
| Q1 2021 | $3,697,000 | +1305.7% | 36,406 | +1279.0% | 0.02% | +1000.0% |
| Q4 2020 | $263,000 | -69.9% | 2,640 | -85.0% | 0.00% | -85.7% |
| Q2 2020 | $875,000 | -55.5% | 17,551 | -73.3% | 0.01% | -72.0% |
| Q1 2020 | $1,965,000 | +1.5% | 65,799 | +14.5% | 0.05% | +316.7% |
| Q4 2019 | $1,936,000 | +117.8% | 57,457 | +112.0% | 0.01% | +50.0% |
| Q3 2019 | $889,000 | -58.1% | 27,100 | -64.8% | 0.01% | -61.9% |
| Q2 2019 | $2,122,000 | -40.3% | 76,932 | -55.4% | 0.02% | -44.7% |
| Q1 2019 | $3,557,000 | +70.8% | 172,501 | +15.6% | 0.04% | +58.3% |
| Q4 2018 | $2,082,000 | -14.1% | 149,160 | +47.2% | 0.02% | -17.2% |
| Q3 2018 | $2,425,000 | +106.9% | 101,300 | +62.7% | 0.03% | +81.2% |
| Q2 2018 | $1,172,000 | +822.8% | 62,273 | +355.6% | 0.02% | +700.0% |
| Q1 2018 | $127,000 | -14.8% | 13,667 | -17.5% | 0.00% | -33.3% |
| Q4 2017 | $149,000 | -4.5% | 16,561 | +36.9% | 0.00% | 0.0% |
| Q3 2017 | $156,000 | +36.8% | 12,100 | +15.2% | 0.00% | +50.0% |
| Q2 2017 | $114,000 | -47.5% | 10,500 | -43.3% | 0.00% | -77.8% |
| Q4 2016 | $217,000 | – | 18,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |